Mortality due to non-AIDS-defining cancers among people living with HIV in Spain over 18 years of follow-up

被引:0
作者
I. Suárez-García
Félix Gutierrez
José A. Pérez-Molina
Santiago Moreno
Teresa Aldamiz
Eulalia Valencia Ortega
Adrián Curran
Sara Gutiérrez González
Víctor Asensi
Concha Amador Prous
Inma Jarrin
Marta Rava
机构
[1] Servicio de Medicina Interna,Grupo de Enfermedades Infecciosas
[2] Hospital Universitario Infanta Sofía,CIBER de Enfermedades Infecciosas
[3] FIIB HUIS HHEN,Department of Medicine
[4] Instituto de Salud Carlos III,Infectious Diseases Department
[5] Universidad Europea de Madrid,Infectious Diseases Unit
[6] Hospital General Universitario de Elche and Universidad Miguel Hernández,Centro Nacional de Epidemiologia
[7] Hospital Universitario Ramón y Cajal,undefined
[8] IRYCIS,undefined
[9] Hospital Gregorio Marañón Servicio de Enfermedades Infecciosas/Microbiología Clínica Instituto de Investigación Gregorio Marañón,undefined
[10] Hospital Universitario La Paz,undefined
[11] Vall d’Hebron Research Institute (VHIR),undefined
[12] Hospital Universitari Vall d’Hebron,undefined
[13] Servicio de Medicina Interna,undefined
[14] Hospital Clínico Universitario de Valladolid,undefined
[15] Hospital Universitario Central de Asturias and Group of Translational Research in Infectious Diseases,undefined
[16] Instituto de Investigación Sanitaria del Principado de Asturias (ISPA),undefined
[17] Hospital de La Marina Baixa,undefined
[18] Instituto de Salud Carlos III,undefined
来源
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词
Cancer; Mortality; HIV; Cohort study;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:18161 / 18171
页数:10
相关论文
共 120 条
[1]  
Aldaz P(2011)Mortality by causes in HIV-infected adults: comparison with the general population BMC Public Health 11 300-2566
[2]  
Moreno-Iribas C(2018)Global patterns of mortality in international migrants: a systematic review and meta-analysis Lancet 392 2553-324
[3]  
Egüés N(2016)Overall and cause-specific excess mortality in HIV-positive persons compared with the general population: role of HCV coinfection Medicine (Baltimore) 95 317-2518
[4]  
Aldridge RW(2004)Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy Cancer 101 2517-432
[5]  
Nellums LB(2018)Do migrants have a mortality advantage? Lancet 392 425-1311
[6]  
Bartlett S(2005)Cancer risk in the Swiss HIV cohort study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy J Natl Cancer Inst 97 1301-853
[7]  
Alejos B(2021)The prevalence and burden of non-AIDS comorbidities among women living with or at risk for human immunodeficiency virus infection in the United States Clin Infect Dis 72 843-e46
[8]  
Hernando V(2019)Cancer disparities in people with HIV: a systematic review of screening for non-AIDS–defining malignancies Cancer 125 e35-2153
[9]  
Iribarren J(2017)Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an analysis of a national observational cohort Lancet Public Heal 2 2143-433
[10]  
Bonnet F(2008)HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies AIDS 22 427-643